ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO4 | Anoctamin 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
ARC | Activity-regulated cytoskeleton-associated protein | | | | | | Tissue enhanced |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTC-360G5.8 | Serine--tRNA ligase, mitochondrial | | | | | | Tissue enhanced |
DFNB31 | Deafness, autosomal recessive 31 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DNAJC12 | DnaJ (Hsp40) homolog, subfamily C, member 12 | | | | | | Tissue enhanced |
FIBCD1 | Fibrinogen C domain containing 1 | | | | | | Tissue enhanced |
FNDC4 | Fibronectin type III domain containing 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
GPR123 | G protein-coupled receptor 123 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HOXA5 | Homeobox A5 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
INHA | Inhibin, alpha | Predicted secreted proteins
| | | | | Tissue enhanced |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KLHL4 | Kelch-like family member 4 | | | | | | Tissue enhanced |
LONRF2 | LON peptidase N-terminal domain and ring finger 2 | | | | | | Tissue enhanced |
MAPK4 | Mitogen-activated protein kinase 4 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
MYO7A | Myosin VIIA | Cytoskeleton related proteins Disease related genes
| | | | | Tissue enhanced |
NDRG4 | NDRG family member 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
NPTX2 | Neuronal pentraxin II | Predicted secreted proteins
| | | | | Tissue enhanced |
NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | Cancer-related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
PCSK2 | Proprotein convertase subtilisin/kexin type 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
PEG10 | Paternally expressed 10 | | | | | | Tissue enhanced |
PRPH | Peripherin | | | | | | Tissue enhanced |
RFX6 | Regulatory factor X, 6 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
RTBDN | Retbindin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SCG5 | Secretogranin V (7B2 protein) | Predicted secreted proteins
| | | | | Tissue enhanced |
SEPT4 | Septin 4 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
SERPINA5 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC27A6 | Solute carrier family 27 (fatty acid transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SULT2A1 | Sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | Enzymes
| | | | | Tissue enhanced |
SYT2 | Synaptotagmin II | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TBX3 | T-box 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
TMIE | Transmembrane inner ear | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TPD52L1 | Tumor protein D52-like 1 | Plasma proteins
| | | | | Tissue enhanced |
UNC80 | Unc-80 homolog (C. elegans) | | | | | | Tissue enhanced |
VAT1L | Vesicle amine transport 1-like | Plasma proteins
| | | | | Tissue enhanced |
ZBED6CL | ZBED6 C-terminal like | | | | | | Tissue enhanced |